KALA BIO raises $10M in registered direct offering of common stock and pre-funded warrants

KALA BIO, Inc.

Sold 900K shares and pre-funded warrants for 9.1M shares at $1.00 per share (warrants at $0.9999).
Gross proceeds of $10M; net proceeds to be used to repay indebtedness and for general corporate purposes.
Offering closed on December 5, 2025; H.C. Wainwright & Co. acted as exclusive placement agent.
Placement agent fee of 8.0% of gross proceeds plus $50K legal and $15,950 clearing expenses.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.